Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey L Probstfield

Showing results (11-20 of 90) with videos related to

Pageof 9
Sort By:
The American Journal of Cardiology|December 14, 2011
Age modification of the association of lipoprotein, lipid, and lipoprotein ratio with carotid intima-media thickness (from the Multi-Ethnic Study of Atherosclerosis [MESA])Pathmaja Paramsothy, Ronit Katz, David S Owens, et al.
JAMA|January 18, 2006
Erectile dysfunction and subsequent cardiovascular diseaseIan M Thompson, Catherine M Tangen, Phyllis J Goodman, et al.
Atherosclerosis|November 26, 2008
Relationship between coronary artery and descending thoracic aortic calcification as detected by computed tomography: the Multi-Ethnic Study of AtherosclerosisJunichiro Takasu, Matthew J Budoff, Kevin D O'Brien, et al.
The New England Journal of Medicine|July 12, 2014
Safety profile of extended-release niacin in the AIM-HIGH trialTodd J Anderson, William E Boden, Patrice Desvigne-Nickens, et al.
Circulation|October 23, 2002
Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasmaKevin D O'Brien, David M Shavelle, Michael T Caulfield, et al.
Ebiomedicine|March 18, 2026
Harnessing metabolomics and proteomics in a clinical trial for pulmonary arterial hypertension: insights from post-hoc analysis of the REHAB-PH trialHongyang Pi, Lu Xia, Samuel G Rayner, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 8, 2006
Incidence and predictors of angioedema in elderly hypertensive patients at high risk for cardiovascular disease: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Linda B Piller, Charles E Ford, Barry R Davis, et al.
Circulation|December 6, 2012
Relationship between healthy diet and risk of cardiovascular disease among patients on drug therapies for secondary prevention: a prospective cohort study of 31 546 high-risk individuals from 40 countriesMahshid Dehghan, Andrew Mente, Koon K Teo, et al.
Journal of Clinical Lipidology|August 23, 2018
Cardiovascular outcomes during extended follow-up of the AIM-HIGH trial cohortJeffrey L Probstfield, William E Boden, Todd Anderson, et al.
Diabetes Care|June 13, 2015
Design of FLAT-SUGAR: Randomized Trial of Prandial Insulin Versus Prandial GLP-1 Receptor Agonist Together With Basal Insulin and Metformin for High-Risk Type 2 Diabetes, Jeffrey L Probstfield, Irl Hirsch, et al.
Pageof 9

Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
The American Journal of Cardiology|December 14, 2011
Age modification of the association of lipoprotein, lipid, and lipoprotein ratio with carotid intima-media thickness (from the Multi-Ethnic Study of Atherosclerosis [MESA])Pathmaja Paramsothy, Ronit Katz, David S Owens, et al.
JAMA|January 18, 2006
Erectile dysfunction and subsequent cardiovascular diseaseIan M Thompson, Catherine M Tangen, Phyllis J Goodman, et al.
Atherosclerosis|November 26, 2008
Relationship between coronary artery and descending thoracic aortic calcification as detected by computed tomography: the Multi-Ethnic Study of AtherosclerosisJunichiro Takasu, Matthew J Budoff, Kevin D O'Brien, et al.
The New England Journal of Medicine|July 12, 2014
Safety profile of extended-release niacin in the AIM-HIGH trialTodd J Anderson, William E Boden, Patrice Desvigne-Nickens, et al.
Circulation|October 23, 2002
Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasmaKevin D O'Brien, David M Shavelle, Michael T Caulfield, et al.
Ebiomedicine|March 18, 2026
Harnessing metabolomics and proteomics in a clinical trial for pulmonary arterial hypertension: insights from post-hoc analysis of the REHAB-PH trialHongyang Pi, Lu Xia, Samuel G Rayner, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 8, 2006
Incidence and predictors of angioedema in elderly hypertensive patients at high risk for cardiovascular disease: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Linda B Piller, Charles E Ford, Barry R Davis, et al.
Circulation|December 6, 2012
Relationship between healthy diet and risk of cardiovascular disease among patients on drug therapies for secondary prevention: a prospective cohort study of 31 546 high-risk individuals from 40 countriesMahshid Dehghan, Andrew Mente, Koon K Teo, et al.
Journal of Clinical Lipidology|August 23, 2018
Cardiovascular outcomes during extended follow-up of the AIM-HIGH trial cohortJeffrey L Probstfield, William E Boden, Todd Anderson, et al.
Diabetes Care|June 13, 2015
Design of FLAT-SUGAR: Randomized Trial of Prandial Insulin Versus Prandial GLP-1 Receptor Agonist Together With Basal Insulin and Metformin for High-Risk Type 2 Diabetes, Jeffrey L Probstfield, Irl Hirsch, et al.
Pageof 9